About this episode

Bernie and Anthony discuss significant changes in cytarabine dosing for AML consolidation based on a recent article.

In this episode, Bernie and Anthony talk about some BIG changes in cytarabine dosing in AML consolidation after a recent practice changing article. Will this change your practice? Hunault, et al. NEJM. 2025. https://evidence.nejm.org/doi/full/10.1056/EVIDoa2400326

People in this episode

Hosts: Bernie, Anthony

Topics covered

• cytarabine dosing
• AML consolidation
• practice changes
• medical research
• oncology

Keywords

• cytarabine
• AML
• dosing
• medical practice
• oncology
• NEJM
• research

Mentioned in this episode

Products: cytarabine

Books & works: Hunault, et al. NEJM. 2025

More episodes of WolverHeme Happy Hour

• Spring Cleaning the Evidence from ASH 2025 with Common Sense Oncology · April 13, 2026 · 1h 1m
• HLH: From Chaos to Clarity... and Back to Chaos! · March 20, 2026 · 1h 5m
• An Exercise in Uncertainty with Jonathan Gluck · February 10, 2026 · 46 min
• ASH Leukemia Review: the more we learn, the less we know! · December 17, 2025 · 1h 23m
• RIP 7+3 (1973-2025)? Why PARADIGM Doesn't Deliver the Eulogy · December 8, 2025 · 41 min
• MajesTEC-3 and ASH 2025: Let's get "TEC"nical · November 25, 2025 · 1h 10m

Explore listener stats, chart rankings, contacts and more on the WolverHeme Happy Hour podcast page.